Single-Cell RNA-Sequencing (Chromium by 10x)
- Samples: tumor biopsies, surgical pieces, peripheral blood, organoids, cell cultures
- Readouts: single-cell gene expression, immune profiling, cell surface proteins, TCR/BCR sequencing, antigen specificity
- Multiplexing: up to 128 samples per run
Single-Cell Spatial Transcriptomics (Xenium by 10x)
- Samples: FFPE samples (in-house capacities for the processing of tumor biopsies)
- Readouts: Spatial gene expression map to identify cell populations in the TME, signaling pathway status, extracellular matrix components, spatial heterogeneity and clonal architecture
- Panels: Prime 5K (5,001 genes) and IO (360 genes) panels available
Experts
in Immuno-Oncology
- 10-year experience: Over 10,000 samples processed to explore mechanisms associated with sensitivity to cancer therapies.
- 30+ peer-reviewed papers released over the past 5 years
- A comprehensive translational platform to complement & validate scRNAseq datasets
Personalized
approach
- Custom single-cell workflow from sample to data analysis
- A dedicated study director (PhD) to tailor the experimental plan to your need and discuss results
- In-house capacities in single-cell data analysis to make the most of your dataset
Your contacts
Talk to our team !
Paul Marteau, PharmD (preclinical study director), Imane Nafia, PhD (CSO), Loïc Cerf, MSc (COO), Alban Bessede, PhD (founder, CEO), Jean-Philippe Guégan, PhD (CTO)
Tell us about your project !
Single-cell analysis for immuno-oncology I CRO Services
Explicyte Immuno-Oncology provides single-cell analysis services in tumor specimens for the discovery of novel targets, predictive biomarkers, and to assess cancer immunotherapy candidates. Our single-cell platform includes scRNAseq and single-cell spatial transcriptomics.